
Press Archive
ProBioGen signs therapeutic protein process development contract with Virdante Pharmaceuticals
ProBioGen Is Granted Divisional Patent on Its Proprietary AGE1 Cell Line
ProBioGen Announces the Appointment of Dr. Volker Sandig to Chief Scientific Officer
ProBioGen presents new data on its Human Artificial Lymph Node (HuALN) technology
Rhein Minapharm and ProBioGen Announce Additional Cell Line Development Agreement
Functional Genetics and ProBioGen Close Antibody Production Agreement
ProBioGen and Boehringer Ingelheim enter into Strategic Production Alliance
ProBioGen announces exclusive licensing agreement for its proprietary avian cell line AGE1.CR
ProBioGen AG fastest growing life sciences company in Deloitte's Technology Fast 50 ranking
Dr Gertraud Unterrainer Joins ProBioGen as Chief Financial Officer
ProBioGen and Minapharm Enter into Development and Co-promotion Agreements
Affitech Contracts with ProBioGen for Producer Cell Line Generation
ProBioGen Wins Prize in STEP Award Competition (Press Release available in German language only)
ProBioGen and Evotec Technologies Successful Completion of Joint Development Collaboration
ProBioGen Signed Agreement on Testing of Neuronal Cell Lines with Serono
Agreement on development contract: ProBioGen and Affimed continue their collaboration
ProBioGen AG Appoints Wiltrud Treffenfeldt to the Supervisory Board
ProBioGen and Saxonia BioTec collaborate: New types of bioreactors for research and diagnostics
ProBioGen Signs Deal with Leading Biopharmaceutical Company for Cell Line Development
ProBioGen and IDT develop novel cell lines for manufacture of live vaccines
ProBioGen AG builds Management and Business Development Team
Cell-line and GMP-specialist ProBioGen reinforces its lead on the market
ProBioGen initiiert Entwicklung eines künstlichen menschlichen Immunorgans